Skip to content Skip to sidebar Skip to footer

GoodRx appoints IQVIA CFO to board for financial expertise By Investing.com

SANTA MONICA, Calif. – GoodRx Holdings, Inc. (NASDAQ: GDRX), a leading prescription savings platform in the United States, announced today the appointment of Ronald E. Bruehlman to its Board of Directors, effective November 8, 2024. Bruehlman, who is the current Chief Financial Officer of IQVIA, brings nearly four decades of experience in finance within the healthcare sector.

Bruehlman’s career spans 39 years, with notable positions including CFO roles at IMS Health and a 23-year tenure at United Technologies Corporation (NYSE:), where he held various senior financial leadership positions. His experience also extends to board memberships at companies such as Atotech Ltd., Q-Squared Solutions, and Clipper Windpower.

In his new role at GoodRx, Bruehlman will chair the Board’s Audit and Risk Committee, succeeding Julie Bradley, who will resign from the GoodRx Board on the same date….

Read the full article…